{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Osimertinib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Osimertinib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Osimertinib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "osimertinib",
    "trial_2_text": "Osimertinib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Osimertinib Supplement: 60 participants will take Osimertinib 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Osimertinib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Osimertinib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.48949265480041504,
      "64": 0.30045178532600403,
      "123": 0.22345981001853943,
      "189": 0.21859773993492126,
      "78": 0.20129916071891785,
      "67": 0.18918967247009277,
      "188": 0.18540401756763458,
      "136": 0.1828034371137619,
      "173": 0.15114668011665344,
      "228": 0.14508584141731262,
      "49": 0.13691352307796478,
      "20": 0.1341986209154129,
      "46": 0.12895648181438446,
      "17": 0.12894156575202942,
      "21": 0.12523013353347778,
      "9": 0.1233295425772667,
      "37": 0.12170711159706116,
      "101": 0.1137344092130661,
      "68": 0.11287881433963776,
      "343": 0.11209096759557724,
      "211": 0.10622477531433105,
      "396": 0.1045638769865036,
      "200": 0.10199927538633347,
      "191": 0.1012112945318222,
      "131": 0.10059512406587601,
      "257": 0.100276879966259,
      "177": 0.09371402114629745,
      "441": 0.09007388353347778,
      "261": 0.08595290035009384,
      "4": 0.0810273289680481,
      "126": 0.08080706000328064,
      "29": 0.08061964064836502,
      "30": 0.0804423987865448,
      "114": 0.08025828748941422,
      "5": 0.08010552078485489,
      "239": 0.07953428477048874,
      "179": 0.07937733083963394,
      "61": 0.07920246571302414,
      "99": 0.07808772474527359,
      "38": 0.07775194197893143,
      "147": 0.0765172690153122,
      "77": 0.0756496712565422,
      "243": 0.07360750436782837,
      "151": 0.07130187004804611,
      "350": 0.07091385871171951,
      "14": 0.07048942148685455,
      "85": 0.06921417266130447,
      "104": 0.06831363588571548,
      "2": 0.06830475479364395,
      "204": 0.06787299364805222,
      "130": 0.06690589338541031,
      "18": 0.06382572650909424,
      "28": 0.06367768347263336,
      "76": 0.06155576556921005,
      "79": 0.06048021838068962,
      "382": 0.06028911471366882,
      "269": 0.05898042768239975,
      "35": 0.05893195420503616,
      "186": 0.058336514979600906,
      "454": 0.05773874372243881,
      "356": 0.0575655922293663,
      "116": 0.05696197599172592,
      "139": 0.05645233392715454,
      "40": 0.05636986345052719,
      "138": 0.056305188685655594,
      "253": 0.055427126586437225,
      "193": 0.05501032993197441,
      "341": 0.05358925461769104,
      "466": 0.05339774116873741,
      "82": 0.05320386216044426,
      "33": 0.05248212069272995,
      "371": 0.05236781761050224,
      "249": 0.05207730829715729,
      "27": 0.0514121875166893,
      "194": 0.050676360726356506,
      "86": 0.049318160861730576,
      "142": 0.04864545911550522,
      "44": 0.0480109266936779,
      "276": 0.047989606857299805,
      "288": 0.04759148135781288,
      "36": 0.04658960923552513,
      "355": 0.046346358954906464,
      "339": 0.04605454206466675,
      "212": 0.04553581401705742,
      "286": 0.04510732367634773,
      "69": 0.04483596235513687,
      "122": 0.044134434312582016,
      "72": 0.04400477558374405,
      "75": 0.04318574443459511,
      "92": 0.04305349662899971,
      "98": 0.04282095283269882,
      "115": 0.04258647933602333,
      "96": 0.042484868317842484,
      "282": 0.04247185215353966,
      "108": 0.042168475687503815,
      "351": 0.042053330689668655,
      "102": 0.0418330617249012,
      "121": 0.04179619997739792,
      "83": 0.04146561771631241,
      "31": 0.04111124947667122
    },
    "trial_2_ae": {
      "87": 0.48949265480041504,
      "64": 0.30045178532600403,
      "123": 0.22345981001853943,
      "189": 0.21859773993492126,
      "78": 0.20129916071891785,
      "67": 0.18918967247009277,
      "188": 0.18540401756763458,
      "136": 0.1828034371137619,
      "173": 0.15114668011665344,
      "228": 0.14508584141731262,
      "49": 0.13691352307796478,
      "20": 0.1341986209154129,
      "46": 0.12895648181438446,
      "17": 0.12894156575202942,
      "21": 0.12523013353347778,
      "9": 0.1233295425772667,
      "37": 0.12170711159706116,
      "101": 0.1137344092130661,
      "68": 0.11287881433963776,
      "343": 0.11209096759557724,
      "211": 0.10622477531433105,
      "396": 0.1045638769865036,
      "200": 0.10199927538633347,
      "191": 0.1012112945318222,
      "131": 0.10059512406587601,
      "257": 0.100276879966259,
      "177": 0.09371402114629745,
      "441": 0.09007388353347778,
      "261": 0.08595290035009384,
      "4": 0.0810273289680481,
      "126": 0.08080706000328064,
      "29": 0.08061964064836502,
      "30": 0.0804423987865448,
      "114": 0.08025828748941422,
      "5": 0.08010552078485489,
      "239": 0.07953428477048874,
      "179": 0.07937733083963394,
      "61": 0.07920246571302414,
      "99": 0.07808772474527359,
      "38": 0.07775194197893143,
      "147": 0.0765172690153122,
      "77": 0.0756496712565422,
      "243": 0.07360750436782837,
      "151": 0.07130187004804611,
      "350": 0.07091385871171951,
      "14": 0.07048942148685455,
      "85": 0.06921417266130447,
      "104": 0.06831363588571548,
      "2": 0.06830475479364395,
      "204": 0.06787299364805222,
      "130": 0.06690589338541031,
      "18": 0.06382572650909424,
      "28": 0.06367768347263336,
      "76": 0.06155576556921005,
      "79": 0.06048021838068962,
      "382": 0.06028911471366882,
      "269": 0.05898042768239975,
      "35": 0.05893195420503616,
      "186": 0.058336514979600906,
      "454": 0.05773874372243881,
      "356": 0.0575655922293663,
      "116": 0.05696197599172592,
      "139": 0.05645233392715454,
      "40": 0.05636986345052719,
      "138": 0.056305188685655594,
      "253": 0.055427126586437225,
      "193": 0.05501032993197441,
      "341": 0.05358925461769104,
      "466": 0.05339774116873741,
      "82": 0.05320386216044426,
      "33": 0.05248212069272995,
      "371": 0.05236781761050224,
      "249": 0.05207730829715729,
      "27": 0.0514121875166893,
      "194": 0.050676360726356506,
      "86": 0.049318160861730576,
      "142": 0.04864545911550522,
      "44": 0.0480109266936779,
      "276": 0.047989606857299805,
      "288": 0.04759148135781288,
      "36": 0.04658960923552513,
      "355": 0.046346358954906464,
      "339": 0.04605454206466675,
      "212": 0.04553581401705742,
      "286": 0.04510732367634773,
      "69": 0.04483596235513687,
      "122": 0.044134434312582016,
      "72": 0.04400477558374405,
      "75": 0.04318574443459511,
      "92": 0.04305349662899971,
      "98": 0.04282095283269882,
      "115": 0.04258647933602333,
      "96": 0.042484868317842484,
      "282": 0.04247185215353966,
      "108": 0.042168475687503815,
      "351": 0.042053330689668655,
      "102": 0.0418330617249012,
      "121": 0.04179619997739792,
      "83": 0.04146561771631241,
      "31": 0.04111124947667122
    }
  },
  "safety": {
    "trial_1_safety": 0.3162100613117218,
    "trial_2_safety": 0.3162100613117218
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.4753648340702057
  }
}